Lymphangiogenesis: In vitro and in vivo models

FASEB Journal

Volumn 24, Issue 1, 2010, Pages 8-21

  Bruyère, Françoise ^a   Noël, Agnès ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

Graft rejection; Lymphatic endothelial cell; Lymphedema; Metastatic dissemination

Indexed keywords

CELL MARKER; VASCULOTROPIN; VASCULOTROPIN RECEPTOR;

CANCER CELL; CELL CULTURE; CELL INTERACTION; CELL ISOLATION; DISEASE MODEL; ENDOTHELIUM CELL; GRAFT REJECTION; HUMAN; IMMUNOCOMPETENT CELL; LYMPH NODE METASTASIS; LYMPH VESSEL; LYMPH VESSEL ENDOTHELIUM; LYMPHANGIOGENESIS; LYMPHANGIOMA; LYMPHEDEMA; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW;

ANIMALS; CELL CULTURE TECHNIQUES; CELLS, CULTURED; DISEASE MODELS, ANIMAL; ENDOTHELIAL CELLS; HUMANS; LYMPHANGIOGENESIS; LYMPHANGIOMA; LYMPHATIC METASTASIS; LYMPHATIC VESSELS; LYMPHEDEMA; MODELS, BIOLOGICAL; ORGAN CULTURE TECHNIQUES;

EID: 75149113630     PISSN: 08926638     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.09-132852     Document Type: Review

References (196)

1. Karpanen, T., and Alitalo, K. (2008) Molecular biology and pathology of lymphangiogenesis. Annu. Rev. Pathol. 3, 367-397
2. Pedica, F., Ligorio, C., Tonelli, P., Bartolini, S., and Baccarini, P. (2008) Lymphangiogenesis in Crohn's disease: an immunohistochemical study using monoclonal antibody D2-40. Virchows. Arch. 452, 57-63
3. Henno, A., Blacher, S., Lambert, C., Colige, A., Seidel, L., Noel, A., Lapiere, C., de la Brassinne, M., and Nusgens, B. V. (2009) Altered expression of angiogenesis and lymphangiogenesis markers in the uninvolved skin of plaque-type psoriasis. Br. J. Dermatol. 160, 581-590
4. Kunstfeld, R., Hirakawa, S., Hong, Y. K., Schacht, V., Lange-Asschenfeldt, B., Velasco, P., Lin, C., Fiebiger, E., Wei, X., Wu, Y., Hicklin, D., Bohlen, P., and Detmar, M. (2004) Induction of cutaneous delayed-type hypersensitivity reactions in vegf-a transgenic mice results in chronic skin inflammation associated with persistent lymphatic hyperplasia. Blood 104, 1048-1057
5. Kerjaschki, D., Regele, H. M., Moosberger, I., Nagy-Bojarski, K., Watschinger, B., Soleiman, A., Birner, P., Krieger, S., Hovorka, A., Silberhumer, G., Laakkonen, P., Petrova, T., Langer, B., and Raab, I. (2004) Lymphatic neoangiogenesis in human kidney transplants is associated with immunologically active lymphocytic infiltrates. J. Am. Soc. Nephrol. 15, 603-612
6. Cursiefen, C., Chen, L., Dana, M. R., and Streilein, J. W. (2003) Corneal lymphangiogenesis: evidence, mechanisms, and implications for corneal transplant immunology. Cornea 22, 273-281
7. Sleeman, J. P., and Thiele, W. (2009) Tumor metastasis and the lymphatic vasculature. [E-pub ahead of print] Int. J. Cancer doi: 10.1002/ijc.24702
8. Cueni, L. N., and Detmar, M. (2006) New insights into the molecular control of the lymphatic vascular system and its role in disease. J. Invest. Dermatol. 126, 2167-2177
9. Adams, R. H., and Alitalo, K. (2007) Molecular regulation of angiogenesis and lymphangiogenesis. Nat. Rev. Mol. Cell. Biol. 8, 464-478
10. Gnepp, D. R., and Chandler, W. (1985) Tissue culture of human and canine thoracic duct endothelium. In Vitro Cell. Dev. Biol. 21, 200-206
11. Djoneidi, M., and Brodt, P. (1991) Isolation and characterization of rat lymphatic endothelial cells. Microcirc. Endoth. Lymph. 7, 161-182
12. Pepper, M. S., Wasi, S., Ferrara, N., Orci, L., and Montesano, R. (1994) In vitro angiogenic and proteolytic properties of bovine lymphatic endothelial cells. Exp. Cell. Res. 210, 298-305
13. Mizuno, R., Yokoyama, Y., Ono, N., Ikomi, F., and Ohhashi, T. (2003) Establishment of rat lymphatic endothelial cell line. Microcirculation 10, 127-131
14. Leak, L. V., and Jones, M. (1994) Lymphangiogenesis in vitro: formation of lymphatic capillary-like channels from confluent monolayers of lymphatic endothelial cells. In Vitro Cell. Dev. Biol. Anim. 30A, 512-518
15. Tan, Y. (1998) Basic fibroblast growth factor-mediated lymphangiogenesis of lymphatic endothelial cells isolated from dog thoracic ducts: effects of heparin. Jpn. J. Physiol. 48, 133-141
16. Shao, X. J., Lu, W. Q., and Liu, C. (2008) Different effects of angiogenesis inhibitors IFN-alpha and TIMP-1 on lymphangiogenesis. Lymphology 41, 64-74
17. Ota, H., Katsube, K., Ogawa, J., and Yanagishita, M. (2007) Hypoxia/Notch signaling in primary culture of rat lymphatic endothelial cells. FEBS Lett. 581, 5220-5226
18. Matsuo, M., Koizumi, K., Yamada, S., Tomi, M., Takahashi, R., Ueda, M., Terasaki, T., Obinata, M., Hosoya, K., Ohtani, O., and Saiki, I. (2006) Establishment and characterization of conditionally immortalized endothelial cell lines from the thoracic duct and inferior vena cava of tsA58/EGFP doubletransgenic rats. Cell Tissue Res. 326, 749-758
19. Davison, P. M., Bensch, K., and Karasek, M. A. (1980) Isolation and growth of endothelial cells from the microvessels of the newborn human foreskin in cell culture. J. Invest. Dermatol. 75, 316-321
20. Baluk, P., and McDonald, D. M. (2008) Markers for microscopic imaging of lymphangiogenesis and angiogenesis. Ann. N. Y. Acad. Sci. 1131, 1-12
21. Kriehuber, E., Breiteneder-Geleff, S., Groeger, M., Soleiman, A., Schoppmann, S. F., Stingl, G., Kerjaschki, D., and Maurer, D. (2001) Isolation and characterization of dermal lymphatic and blood endothelial cells reveal stable and functionally specialized cell lineages. J. Exp. Med. 194, 797- 808
22. Podgrabinska, S., Braun, P., Velasco, P., Kloos, B., Pepper, M. S., and Skobe, M. (2002) Molecular characterization of lymphatic endothelial cells. Proc. Natl. Acad. Sci. U. S. A. 99, 16069-16074
23. Hirakawa, S., Hong, Y. K., Harvey, N., Schacht, V., Matsuda, K., Libermann, T., and Detmar, M. (2003) Identification of vascular lineage-specific genes by transcriptional profiling of isolated blood vascular and lymphatic endothelial cells. Am. J. Pathol. 162, 575-586
24. Makinen, T., Veikkola, T., Mustjoki, S., Karpanen, T., Catimel, B., Nice, E. C., Wise, L., Mercer, A., Kowalski, H., Kerjaschki, D., Stacker, S. A., Achen, M. G., and Alitalo, K. (2001) Isolated lymphatic endothelial cells transduce growth, survival and migratory signals via the VEGF-C/D receptor VEGFR-3. EMBO J. 20, 4762-4773
25. Hu, X., Jiang, Z., and Liu, N. (2006) A novel approach for harvesting lymphatic endothelial cells from human foreskin dermis. Lymphat. Res. Biol. 4, 191-198
26. Nisato, R. E., Harrison, J. A., Buser, R., Orci, L., Rinsch, C., Montesano, R., Dupraz, P., and Pepper, M. S. (2004) Generation and characterization of telomerase-transfected human lymphatic endothelial cells with an extended life span. Am. J. Pathol. 165, 11-24
27. Petrova, T. V., Makinen, T., Makela, T. P., Saarela, J., Virtanen, I., Ferrell, R. E., Finegold, D. N., Kerjaschki, D., Yla-Herttuala, S., and Alitalo, K. (2002) Lymphatic endothelial reprogramming of vascular endothelial cells by the Prox-1 homeobox transcription factor. EMBO J. 21, 4593-4599
28. Yong, C., Bridenbaugh, E. A., Zawieja, D. C., and Swartz, M. A. (2005) Microarray analysis of VEGF-C-responsive genes in human lymphatic endothelial cells. Lymphat. Res. Biol. 3, 183-207
29. Groger, M., Loewe, R., Holnthoner, W., Embacher, R., Pillinger, M., Herron, G. S., Wolff, K., and Petzelbauer, P. (2004) IL-3 induces expression of lymphatic markers Prox-1 and podoplanin in human endothelial cells. J. Immunol. 173, 7161-7169
30. Groger, M., Niederleithner, H., Kerjaschki, D., and Petzelbauer, P. (2007) A previously unknown dermal blood vessel phenotype in skin inflammation. J. Invest. Dermatol. 127, 2893-2900
31. Amatschek, S., Kriehuber, E., Bauer, W., Reininger, B., Meraner, P., Wolpl, A., Schweifer, N., Haslinger, C., Stingl, G., and Maurer, D. (2007) Blood and lymphatic endothelial cellspecific differentiation programs are stringently controlled by the tissue environment. Blood 109, 4777-4785
32. Hayes, H., Kossmann, E., Wilson, E., Meininger, C., and Zawieja, D. (2003) Development and characterization of endothelial cells from rat microlymphatics. Lymphat. Res. Biol. 1, 101-119
33. Whitehurst, B., Eversgerd, C., Flister, M., Bivens, C. M., Pickett, B., Zawieja, D. C., and Ran, S. (2006) Molecular profile and proliferative responses of rat lymphatic endothelial cells in culture. Lymphat. Res. Biol. 4, 119-142
34. Yamaguchi, T., Ichise, T., Iwata, O., Hori, A., Adachi, T., Nakamura, M., Yoshida, N., and Ichise, H. (2008) Development of a new method for isolation and long-term culture of organ-specific blood vascular and lymphatic endothelial cells of the mouse. FEBS J. 275, 1988-1998
35. Kawai, Y., Hosaka, K., Kaidoh, M., Minami, T., Kodama, T., and Ohhashi, T. (2008) Heterogeneity in immunohistochemical, genomic, and biological properties of human lymphatic endothelial cells between initial and collecting lymph vessels. Lymphat. Res. Biol. 6, 15-27
36. Yamashita, J. K. (2007) Differentiation of arterial, venous, and lymphatic endothelial cells from vascular progenitors. Trends Cardiovasc. Med. 17, 59-63
37. Liersch, R., Nay, F., Lu, L., and Detmar, M. (2006) Induction of lymphatic endothelial cell differentiation in embryoid bodies. Blood 107, 1214-1216
38. Kreuger, J., Nilsson, I., Kerjaschki, D., Petrova, T., Alitalo, K., and Claesson-Welsh, L. (2006) Early lymph vessel development from embryonic stem cells. Arterioscler. Thromb. Vasc. Biol. 26, 1073-1078
39. Kono, T., Kubo, H., Shimazu, C., Ueda, Y., Takahashi, M., Yanagi, K., Fujita, N., Tsuruo, T., Wada, H., and Yamashita, J. K. (2006) Differentiation of lymphatic endothelial cells from embryonic stem cells on OP9 stromal cells. Arterioscler. Thromb. Vasc. Biol. 26, 2070-2076
40. Mancardi, S., Stanta, G., Dusetti, N., Bestagno, M., Jussila, L., Zweyer, M., Lunazzi, G., Dumont, D., Alitalo, K., and Burrone, O. R. (1999) Lymphatic endothelial tumors induced by intraperitoneal injection of incomplete Freund's adjuvant. Exp. Cell. Res. 246, 368-375
41. Short, R. F., Shiels, W. E., 2nd, Sferra, T. J., Nicol, K. K., Schofield, M., and Wiet, G. J. (2007) Site-specific induction of lymphatic malformations in a rat model for image-guided therapy. Pediatr. Radiol. 37, 530-534
42. Mancardi, S., Vecile, E., Dusetti, N., Calvo, E., Stanta, G., Burrone, O. R., and Dobrina, A. (2003) Evidence of CXC, CC and C chemokine production by lymphatic endothelial cells. Immunology 108, 523-530
43. Nakamura, E. S., Koizumi, K., Kobayashi, M., and Saiki, I. (2004) Inhibition of lymphangiogenesis-related properties of murine lymphatic endothelial cells and lymph node metastasis of lung cancer by the matrix metalloproteinase inhibitor MMI270. Cancer Sci. 95, 25-31
44. Chen, S., Chen, A., and Huang, C. (2007) Establishment of lymphangioma model and a study on the promoting effect of murine melanoma cell B16-F1 on the lymphangiogenesis in vitro. J. Huazhong Univ. Sci. Technolog. Med. Sci. 27, 733-735
45. Ezaki, T., Kuwahara, K., Morikawa, S., Shimizu, K., Sakaguchi, N., Matsushima, K., and Matsuno, K. (2006) Production of two novel monoclonal antibodies that distinguish mouse lymphatic and blood vascular endothelial cells. Anat. Embryol. (Berl.) 211, 379-393
46. Ando, T., Jordan, P., Joh, T., Wang, Y., Jennings, M. H., Houghton, J., and Alexander, J. S. (2005) Isolation and characterization of a novel mouse lymphatic endothelial cell line: SV-LEC. Lymphat. Res. Biol. 3, 105-115
47. Wick, N., Saharinen, P., Saharinen, J., Gurnhofer, E., Steiner, C. W., Raab, I., Stokic, D., Giovanoli, P., Buchsbaum, S., Burchard, A., Thurner, S., Alitalo, K., and Kerjaschki, D. (2007) Transcriptomal comparison of human dermal lymphatic endothelial cells ex vivo and in vitro. Physiol. Genomics 28, 179-192
48. Sironi, M., Conti, A., Bernasconi, S., Fra, A. M., Pasqualini, F., Nebuloni, M., Lauri, E., De Bortoli, M., Mantovani, A., Dejana, E., and Vecchi, A. (2006) Generation and characterization of a mouse lymphatic endothelial cell line. Cell Tissue Res. 325, 91-100
49. Johnson, L. A., Clasper, S., Holt, A. P., Lalor, P. F., Baban, D., and Jackson, D. G. (2006) An inflammation-induced mechanism for leukocyte transmigration across lymphatic vessel endothelium. J. Exp. Med. 203, 2763-2777
50. Johnson, L. A., Prevo, R., Clasper, S., and Jackson, D. G. (2007) Inflammation-induced uptake and degradation of the lymphatic endothelial hyaluronan receptor LYVE-1. J. Biol. Chem. 282, 33671-33680
51. Berndt, S., Bruyère, F., Jost, M., and Noël, A. (2008) In vitro and in vivo models of angiogenesis to dissect MMP functions. In The Cancer Degradome-Proteases and Cancer Biology (Edwards, D. R., Hoyer-Hansen, G., Blasi, F., Sloane, B. F., eds) pp. 303-322, Springer Verlag, New York
52. Banziger-Tobler, N. E., Halin, C., Kajiya, K., and Detmar, M. (2008) Growth hormone promotes lymphangiogenesis. Am. J. Pathol. 173, 586-597
53. Cueni, L. N., and Detmar, M. (2009) Galectin-8 interacts with podoplanin and modulates lymphatic endothelial cell functions. Exp. Cell. Res. 315, 1715-1723
54. Alajati, A., Laib, A. M., Weber, H., Boos, A. M., Bartol, A., Ikenberg, K., Korff, T., Zentgraf, H., Obodozie, C., Graeser, R., Christian, S., Finkenzeller, G., Stark, G. B., Heroult, M., and Augustin, H. G. (2008) Spheroid-based engineering of a human vasculature in mice. Nat. Methods 5, 439-445
55. Bielenberg, D. R. (2008) Metastasis: two assays explore the two roads traveled. Nat. Methods. 5, 384-385
56. Ng, C. P., Helm, C. L., and Swartz, M. A. (2004) Interstitial flow differentially stimulates blood and lymphatic endothelial cell morphogenesis in vitro. Microvasc. Res. 68, 258-264
57. Helm, C. L., Fleury, M. E., Zisch, A. H., Boschetti, F., and Swartz, M. A. (2005) Synergy between interstitial flow and VEGF directs capillary morphogenesis in vitro through a gradient amplification mechanism. Proc. Natl. Acad. Sci. U. S. A. 102, 15779-15784
58. Bruyere, F., Melen-Lamalle, L., Blacher, S., Roland, G., Thiry, M., Moons, L., Frankenne, F., Carmeliet, P., Alitalo, K., Libert, C., Sleeman, J. P., Foidart, J. M., and Noel, A. (2008) Modeling lymphangiogenesis in a three-dimensional culture system. Nat. Methods 5, 431-437
59. Bruyere, F., Melen-Lamalle, L., Berndt, S., Peulen, O., Foidart, J. M., and Noel, A. (2008) The lymphatic ring assay: a 3D-culture model of lymphangiogenesis. Nat. Protocols doi: 10.1038/nprot.2008.86
60. Nicosia, R. F. (1987) Angiogenesis and the formation of lymphatic like channels in cultures of thoracic duct. In Vitro Cell. Dev. Biol. 23, 167-174
61. Helm, C. L., Zisch, A., and Swartz, M. A. (2007) Engineered blood and lymphatic capillaries in 3-D VEGF-fibrin-collagen matrices with interstitial flow. Biotechnol. Bioeng. 96, 167-176
62. Hosaka, K., Mizuno, R., and Ohhashi, T. (2003) Rho-Rho kinase pathway is involved in the regulation of myogenic tone and pump activity in isolated lymph vessels. Am. J. Physiol. Heart. Circ. Physiol. 284, H2015-H2025
63. Ono, N., Mizuno, R., and Ohhashi, T. (2005) Effective permeability of hydrophilic substances through walls of lymph vessels: roles of endothelial barrier. Am. J. Physiol. Heart. Circ. Physiol. 289, H1676-1682
64. Mizuno, R., Ono, N., Ikomi, F., and Ohhashi, T. (2005) A new preparation for visualizing lymphatic flow pathway in isolated rat lymph nodes. Lymphat. Res. Biol. 3, 127-136
65. Gashev, A. A., Davis, M. J., and Zawieja, D. C. (2002) Inhibition of the active lymph pump by flow in rat mesenteric lymphatics and thoracic duct. J. Physiol. 540, 1023-1037
66. Gasheva, O. Y., Knippa, K., Nepiushchikh, Z. V., Muthuchamy, M., and Gashev, A. A. (2007) Age-related alterations of active pumping mechanisms in rat thoracic duct. Microcirculation 14, 827-839
67. Giese, C., Demmler, C. D., Ammer, R., Hartmann, S., Lubitz, A., Miller, L., Muller, R., and Marx, U. (2006) A human lymph node in vitro-challenges and progress. Artif. Organs 30, 803-808
68. Nelson, C. M., and Tien, J. (2006) Microstructured extracellular matrices in tissue engineering and development. Curr. Opin. Biotechnol. 17, 518-523
69. Chrobak, K. M., Potter, D. R., and Tien, J. (2006) Formation of perfused, functional microvascular tubes in vitro. Microvasc. Res. 71, 185-196
70. Muthuchamy, M., and Zawieja, D. (2008) Molecular regulation of lymphatic contractility. Ann. N. Y. Acad. Sci. 1131, 89-99
71. Karpanen, T., Wirzenius, M., Makinen, T., Veikkola, T., Haisma, H. J., Achen, M. G., Stacker, S. A., Pytowski, B., Yla-Herttuala, S., and Alitalo, K. (2006) Lymphangiogenic growth factor responsiveness is modulated by postnatal lymphatic vessel maturation. Am. J. Pathol. 169, 708-718
72. Baluk, P., Tammela, T., Ator, E., Lyubynska, N., Achen, M. G., Hicklin, D. J., Jeltsch, M., Petrova, T. V., Pytowski, B., Stacker, S. A., Yla-Herttuala, S., Jackson, D. G., Alitalo, K., and Mc-Donald, D. M. (2005) Pathogenesis of persistent lymphatic vessel hyperplasia in chronic airway inflammation. J. Clin. Invest. 115, 247-257
73. Makinen, T., Jussila, L., Veikkola, T., Karpanen, T., Kettunen, M. I., Pulkkanen, K. J., Kauppinen, R., Jackson, D. G., Kubo, H., Nishikawa, S., Yla-Herttuala, S., and Alitalo, K. (2001) Inhibition of lymphangiogenesis with resulting lymphedema in transgenic mice expressing soluble VEGF receptor-3. Nat. Med. 7, 199-205
74. Petrova, T. V., Karpanen, T., Norrmen, C., Mellor, R., Tamakoshi, T., Finegold, D., Ferrell, R., Kerjaschki, D., Mortimer, P., Yla-Herttuala, S., Miura, N., and Alitalo, K. (2004) Defective valves and abnormal mural cell recruitment underlie lymphatic vascular failure in lymphedema distichiasis. Nat. Med. 10, 974-981
75. Nagy, J. A., Vasile, E., Feng, D., Sundberg, C., Brown, L. F., Detmar, M. J., Lawitts, J. A., Benjamin, L., Tan, X., Manseau, E. J., Dvorak, A. M., and Dvorak, H. F. (2002) Vascular permeability factor/vascular endothelial growth factor induces lymphangiogenesis as well as angiogenesis. J. Exp. Med. 196, 1497-1506
76. Heath, T. J., Brandon, R. A., and Norman, S. T. (1984) Drainage of lymph from the foreleg to the superficial cervical lymph node in sheep. Res. Vet. Sci. 37, 66-71
77. Krishnan, J., Kirkin, V., Steffen, A., Hegen, M., Weih, D., Tomarev, S., Wilting, J., and Sleeman, J. P. (2003) Differential in vivo and in vitro expression of vascular endothelial growth factor (VEGF)-C and VEGF-D in tumors and its relationship to lymphatic metastasis in immunocompetent rats. Cancer Res. 63, 713-722
78. Bollinger, A., Jager, K., Sgier, F., and Seglias, J. (1981) Fluorescence microlymphography. Circulation 64, 1195-1200
79. Swartz, M. A., Kaipainen, A., Netti, P. A., Brekken, C., Boucher, Y., Grodzinsky, A. J., and Jain, R. K. (1999) Mechanics of interstitial-lymphatic fluid transport: theoretical foundation and experimental validation. J. Biomech. 32, 1297-1307
80. Jeltsch, M., Kaipainen, A., Joukov, V., Meng, X., Lakso, M., Rauvala, H., Swartz, M., Fukumura, D., Jain, R. K., and Alitalo, K. (1997) Hyperplasia of lymphatic vessels in VEGF-C transgenic mice. Science 276, 1423-1425
81. Leu, A. J., Berk, D. A., Lymboussaki, A., Alitalo, K., and Jain, R. K. (2000) Absence of functional lymphatics within a murine sarcoma: a molecular and functional evaluation. Cancer Res. 60, 4324-4327
82. Herborn, C. U., Lauenstein, T. C., Vogt, F. M., Lauffer, R. B., Debatin, J. F., and Ruehm, S. G. (2002) Interstitial MR lymphography with MS-325: characterization of normal and tumor-invaded lymph nodes in a rabbit model. AJR Am. J. Roentgenol. 179, 1567-1572
83. Pan, D., Suzuki, Y., Yang, P. C., and Rockson, S. G. (2006) Indirect magnetic resonance lymphangiography to assess lymphatic function in experimental murine lymphedema. Lymphat. Res. Biol. 4, 211-216
84. Hama, Y., Koyama, Y., Urano, Y., Choyke, P. L., and Kobayashi, H. (2007) Two-color lymphatic mapping using Igconjugated near infrared optical probes. J. Invest. Dermatol. 127, 2351-2356
85. Hama, Y., Koyama, Y., Urano, Y., Choyke, P. L., and Kobayashi, H. (2007) Simultaneous two-color spectral fluorescence lymphangiography with near infrared quantum dots to map two lymphatic flows from the breast and the upper extremity. Breast Cancer Res. Treat. 103, 23-28
86. Bhang, S. H., Won, N., Lee, T. J., Jin, H., Nam, J., Park, J., Chung, H., Park, H. S., Sung, Y. E., Hahn, S. K., Kim, B. S., and Kim, S. (2009) Hyaluronic acid-quantum dot conjugates for in vivo lymphatic vessel imaging. ACS Nano 3, 1389-1398
87. Harvey, N. L., Srinivasan, R. S., Dillard, M. E., Johnson, N. C., Witte, M. H., Boyd, K., Sleeman, M. W., and Oliver, G. (2005) Lymphatic vascular defects promoted by Prox1 haploinsufficiency cause adult-onset obesity. Nat. Genet. 37, 1072-1081
88. Koch, M., Dettori, D., Nuffelen, A. V., Souffreau, J., Marconcini, L., Wallays, G., Moons, L., Bruyère, F., Oliviero, S., Noel, A., Foidart, J.-M., Carmeliet, P., and Dewerchin, M. (2009) VEGF-D deficiency in mice does not affect embryonic or postnatal lymphangiogenesis but reduces lymphatic metastasis. J. Pathol. In press
89. Sabin, F. (1902) On the origin of the lymphatic system from the veins and the development of the lymph hearts and thoracic duct in the pig. Am. J. Anat. 1, 367-391
90. Hosking, B., and Makinen, T. (2007) Lymphatic vasculature: a molecular perspective. Bioessays 29, 1192-1202
91. Wigle, J. T., Chowdhury, K., Gruss, P., and Oliver, G. (1999) Prox1 function is crucial for mouse lens-fibre elongation. Nat. Genet. 21, 318-322
92. Karkkainen, M. J., Haiko, P., Sainio, K., Partanen, J., Taipale, J., Petrova, T. V., Jeltsch, M., Jackson, D. G., Talikka, M., Rauvala, H., Betsholtz, C., and Alitalo, K. (2004) Vascular endothelial growth factor C is required for sprouting of the first lymphatic vessels from embryonic veins. Nat. Immunol. 5, 74 - 80
93. Ayadi, A., Zheng, H., Sobieszczuk, P., Buchwalter, G., Moerman, P., Alitalo, K., and Wasylyk, B. (2001) Net-targeted mutant mice develop a vascular phenotype and up-regulate egr-1. EMBO J. 20, 5139-5152
94. Schacht, V., Ramirez, M. I., Hong, Y. K., Hirakawa, S., Feng, D., Harvey, N., Williams, M., Dvorak, A. M., Dvorak, H. F., Oliver, G., and Detmar, M. (2003) T1alpha/podoplanin deficiency disrupts normal lymphatic vasculature formation and causes lymphedema. EMBO J. 22, 3546-3556
95. Yuan, L., Moyon, D., Pardanaud, L., Breant, C., Karkkainen, M. J., Alitalo, K., and Eichmann, A. (2002) Abnormal lymphatic vessel development in neuropilin 2 mutant mice. Development 129, 4797-4806
96. Gale, N. W., Thurston, G., Hackett, S. F., Renard, R., Wang, Q., McClain, J., Martin, C., Witte, C., Witte, M. H., Jackson, D., Suri, C., Campochiaro, P. A., Wiegand, S. J., and Yancopoulos, G. D. (2002) Angiopoietin-2 is required for postnatal angiogenesis and lymphatic patterning, and only the latter role is rescued by Angiopoietin-1. Dev. Cell 3, 411-423
97. Huang, X. Z., Wu, J. F., Ferrando, R., Lee, J. H., Wang, Y. L., Farese, R. V., Jr., and Sheppard, D. (2000) Fatal bilateral chylothorax in mice lacking the integrin alpha9beta1. Mol. Cell. Biol. 20, 5208-5215
98. Fruman, D. A., Mauvais-Jarvis, F., Pollard, D. A., Yballe, C. M., Brazil, D., Bronson, R. T., Kahn, C. R., and Cantley, L. C. (2000) Hypoglycaemia, liver necrosis and perinatal death in mice lacking all isoforms of phosphoinositide 3-kinase p85 alpha. Nat. Genet. 26, 379-382
99. Gittenberger-de Groot, A. C., Van den Akker, N. M., Bartelings, M. M., Webb, S., Van Vugt, J. M., and Haak, M. C. (2004) Abnormal lymphatic development in trisomy-16 mouse embryos precedes nuchal edema. Dev. Dyn. 230, 378-384
100. Kuhnert, F., Campagnolo, L., Xiong, J. W., Lemons, D., Fitch, M. J., Zou, Z., Kiosses, W. B., Gardner, H., and Stuhlmann, H. (2005) Dosage-dependent requirement for mouse Vezf1 in vascular system development. Dev. Biol. 283, 140-156
101. Karpanen, T., and Alitalo, K. (2008) Molecular biology and pathology of lymphangiogenesis. Annu. Rev. Pathol. 3, 367-397
102. Buttler, K., Ezaki, T., and Wilting, J. (2008) Proliferating mesodermal cells in murine embryos exhibiting macrophage and lymphendothelial characteristics. BMC Dev. Biol. 8, 43
103. Parsons-Wingerter, P., McKay, T. L., Leontiev, D., Vickerman, M. B., Condrich, T. K., and Dicorleto, P. E. (2006) Lymphangiogenesis by blind-ended vessel sprouting is concurrent with hemangiogenesis by vascular splitting. Anat. Rec. A Discov. Mol. Cell. Evol. Biol. 288, 233-247
104. Papoutsi, M., Tomarev, S. I., Eichmann, A., Prols, F., Christ, B., and Wilting, J. (2001) Endogenous origin of the lymphatics in the avian chorioallantoic membrane. Dev. Dyn. 222, 238 -251
105. Ny, A., Koch, M., Schneider, M., Neven, E., Tong, R. T., Maity, S., Fischer, C., Plaisance, S., Lambrechts, D., Heligon, C., Terclavers, S., Ciesiolka, M., Kalin, R., Man, W. Y., Senn, I., Wyns, S., Lupu, F., Brandli, A., Vleminckx, K., Collen, D., Dewerchin, M., Conway, E. M., Moons, L., Jain, R. K., and Carmeliet, P. (2005) A genetic Xenopus laevis tadpole model to study lymphangiogenesis. Nat. Med. 11, 998 -1004
106. Ny, A., Autiero, M., and Carmeliet, P. (2006) Zebrafish and Xenopus tadpoles: Small animal models to study angiogenesis and lymphangiogenesis. Exp. Cell. Res. 312, 684-693
107. Ny, A., Koch, M., Vandevelde, W., Schneider, M., Fischer, C., Diez-Juan, A., Neven, E., Geudens, I., Maity, S., Moons, L., Plaisance, S., Lambrechts, D., Carmeliet, P., and Dewerchin, M. (2008) Role of VEGF-D and VEGFR-3 in developmental lymphangiogenesis, a chemicogenetic study in Xenopus tadpoles. Blood 112, 1740-1749
108. Kalin, R. E., Banziger-Tobler, N. E., Detmar, M., and Brandli, A. W. (2009) An in vivo chemical library screen in Xenopus tadpoles reveals novel pathways involved in angiogenesis and lymphangiogenesis. Blood 114, 1110-1122
109. Yaniv, K., Isogai, S., Castranova, D., Dye, L., Hitomi, J., and Weinstein, B. M. (2006) Live imaging of lymphatic development in the zebrafish. Nat. Med. 12, 711-716
110. Kuchler, A. M., Gjini, E., Peterson-Maduro, J., Cancilla, B., Wolburg, H., and Schulte-Merker, S. (2006) Development of the zebrafish lymphatic system requires VEGF-C signaling. Curr. Biol. 16, 1244-1248
111. Isogai, S., Hitomi, J., Yaniv, K., and Weinstein, B. M. (2009) Zebrafish as a new animal model to study lymphangiogenesis. Anat. Sci. Int. 84, 102-111
112. Song, M., Yang, H., Yao, S., Ma, F., Li, Z., Deng, Y., Deng, H., Zhou, Q., Lin, S., and Wei, Y. (2007) A critical role of vascular endothelial growth factor D in zebrafish embryonic vasculogenesis and angiogenesis. Biochem. Biophys. Res. Commun. 357, 924-930
113. Shin, W. S., and Rockson, S. G. (2008) Animal models for the molecular and mechanistic study of lymphatic biology and disease. Ann. N. Y. Acad. Sci. 1131, 50-74
114. Radhakrishnan, K., and Rockson, S. G. (2008) The clinical spectrum of lymphatic disease. Ann. N. Y. Acad. Sci. 1131, 155-184
115. Karkkainen, M. J., Saaristo, A., Jussila, L., Karila, K. A., Lawrence, E. C., Pajusola, K., Bueler, H., Eichmann, A., Kauppinen, R., Kettunen, M. I., Yla-Herttuala, S., Finegold, D. N., Ferrell, R. E., and Alitalo, K. (2001) A model for gene therapy of human hereditary lymphedema. Proc. Natl. Acad. Sci. U. S. A. 98, 12677-12682
116. Karlsen, T. V., Karkkainen, M. J., Alitalo, K., and Wiig, H. (2006) Transcapillary fluid balance consequences of missing initial lymphatics studied in a mouse model of primary lymphoedema. J. Physiol. 574, 583-596
117. Kriederman, B. M., Myloyde, T. L., Witte, M. H., Dagenais, S. L., Witte, C. L., Rennels, M., Bernas, M. J., Lynch, M. T., Erickson, R. P., Caulder, M. S., Miura, N., Jackson, D., Brooks, B. P., and Glover, T. W. (2003) FOXC2 haploinsufficient mice are a model for human autosomal dominant lymphedemadistichiasis syndrome. Hum. Mol. Genet. 12, 1179-1185
118. Yla-Herttuala, S., and Alitalo, K. (2003) Gene transfer as a tool to induce therapeutic vascular growth. Nat. Med. 9, 694-701
119. Saaristo, A., Veikkola, T., Tammela, T., Enholm, B., Karkkainen, M. J., Pajusola, K., Bueler, H., Yla-Herttuala, S., and Alitalo, K. (2002) Lymphangiogenic gene therapy with minimal blood vascular side effects. J. Exp. Med. 196, 719-730
120. Dellinger, M. T., Hunter, R. J., Bernas, M. J., Witte, M. H., and Erickson, R. P. (2007) Chy-3 mice are vegfc haploinsufficient and exhibit defective dermal superficial to deep lymphatic transition and dermal lymphatic hypoplasia. Dev. Dyn. 236, 2346-2355
121. Hong, Y. K., Harvey, N., Noh, Y. H., Schacht, V., Hirakawa, S., Detmar, M., and Oliver, G. (2002) Prox1 is a master control gene in the program specifying lymphatic endothelial cell fate. Dev. Dyn. 225, 351-357
122. Slavin, S. A., Van den Abbeele, A. D., Losken, A., Swartz, M. A., and Jain, R. K. (1999) Return of lymphatic function after flap transfer for acute lymphedema. Ann. Surg. 229, 421-427
123. Tabibiazar, R., Cheung, L., Han, J., Swanson, J., Beilhack, A., An, A., Dadras, S. S., Rockson, N., Joshi, S., Wagner, R., and Rockson, S. G. (2006) Inflammatory manifestations of experimental lymphatic insufficiency. PLoS Med. 3, e254
124. Boardman, K. C., and Swartz, M. A. (2003) Interstitial flow as a guide for lymphangiogenesis. Circ. Res. 92, 801-808
125. Saito, Y., Nakagami, H., Kurooka, M., Takami, Y., Kikuchi, Y., Hayashi, H., Nishikawa, T., Tamai, K., Morishita, R., Azuma, N., Sasajima, T., and Kaneda, Y. (2008) Cold shock domain protein A represses angiogenesis and lymphangiogenesis via inhibition of serum response element. Oncogene 27, 1821-1833
126. Rutkowski, J. M., Boardman, K. C., and Swartz, M. A. (2006) Characterization of lymphangiogenesis in a model of adult skin regeneration. Am. J. Physiol. Heart Circ. Physiol. 291, H1402-H1410
127. Rutkowski, J. M., Moya, M., Johannes, J., Goldman, J., and Swartz, M. A. (2006) Secondary lymphedema in the mouse tail: Lymphatic hyperplasia, VEGF-C upregulation, and the protective role of MMP-9. Microvasc. Res. 72, 161-171
128. Uzarski, J., Drelles, M. B., Gibbs, S. E., Ongstad, E. L., Goral, J. C., McKeown, K. K., Raehl, A. M., Roberts, M. A., Pytowski, B., Smith, M. R., and Goldman, J. (2008) The resolution of lymphedema by interstitial flow in the mouse tail skin. Am. J. Physiol. Heart Circ. Physiol. 294, H1326-H1334
129. Cunningham, D. M., Olding, M., and Daniel, R. K. (1978) Microsurgical techniques in experimental lymphedema of the rabbit ear. Surg. Gynecol. Obstet. 147, 877-880
130. Huang, G. K., and Hsin, Y. P. (1983) An experimental model for lymphedema in rabbit ear. Microsurgery 4, 236-242
131. Fu, K., Izquierdo, R., Vandevender, D., Warpeha, R. L., and Fareed, J. (1998) Transplantation of lymph node fragments in a rabbit ear lymphedema model: a new method for restoring the lymphatic pathway. Plast. Reconstr. Surg. 101, 134-141
132. Szuba, A., Skobe, M., Karkkainen, M. J., Shin, W. S., Beynet, D. P., Rockson, N. B., Dakhil, N., Spilman, S., Goris, M. L., Strauss, H. W., Quertermous, T., Alitalo, K., and Rockson, S. G. (2002) Therapeutic lymphangiogenesis with human recombinant VEGF-C. FASEB J. 16, 1985-1987
133. Yoon, Y. S., Murayama, T., Gravereaux, E., Tkebuchava, T., Silver, M., Curry, C., Wecker, A., Kirchmair, R., Hu, C. S., Kearney, M., Ashare, A., Jackson, D. G., Kubo, H., Isner, J. M., and Losordo, D. W. (2003) VEGF-C gene therapy augments postnatal lymphangiogenesis and ameliorates secondary lymphedema. J. Clin. Invest. 111, 717-725
134. Kanter, M. A., Slavin, S. A., and Kaplan, W. (1990) An experimental model for chronic lymphedema. Plast. Reconstr. Surg. 85, 573-580
135. Lee-Donaldson, L., Witte, M. H., Bernas, M., Witte, C. L., Way, D., and Stea, B. (1999) Refinement of a rodent model of peripheral lymphedema. Lymphology 32, 111-117
136. Kriederman, B., Myloyde, T., Bernas, M., Lee-Donaldson, L., Preciado, S., Lynch, M., Stea, B., Summers, P., Witte, C., and Witte, M. (2002) Limb volume reduction after physical treatment by compression and/or massage in a rodent model of peripheral lymphedema. Lymphology 35, 23-27
137. Ikomi, F., Yokoyama, Y., Ogiwara, N., Sasaki, K., Mizuno, R., and Ohhashi, T. (2006) Recanalization of the collecting lymphatics in rabbit hind leg. Microcirculation 13, 365-376
138. Wiegand, S., Eivazi, B., Barth, P. J., von Rautenfeld, D. B., Folz, B. J., Mandic, R., and Werner, J. A. (2008) Pathogenesis of lymphangiomas. Virchows Arch. 453, 1-8
139. Dale, M. M. (1960) The effect of Freund's adjuvants on lymphatics in the mouse's ear. Br. J. Exp. Pathol. 41, 86-88
140. Dale, M. M. (1961) The effect of the components of adjuvant emulsions on lymphatics in the mouse's ear. Br. J. Exp. Pathol. 42, 297-302
141. Saaristo, A., Tammela, T., Farkkila, A., Karkkainen, M., Suominen, E., Yla-Herttuala, S., and Alitalo, K. (2006) Vascular endothelial growth factor-C accelerates diabetic wound healing. Am. J. Pathol. 169, 1080-1087
142. Hong, Y. K., Lange-Asschenfeldt, B., Velasco, P., Hirakawa, S., Kunstfeld, R., Brown, L. F., Bohlen, P., Senger, D. R., and Detmar, M. (2004) VEGF-A promotes tissue repair-associated lymphatic vessel formation via VEGFR-2 and the alpha1beta1 and alpha2beta1 integrins. FASEB J. 18, 1111-1113
143. Paavonen, K., Puolakkainen, P., Jussila, L., Jahkola, T., and Alitalo, K. (2000) Vascular endothelial growth factor receptor-3 in lymphangiogenesis in wound healing. Am. J. Pathol. 156, 1499-1504
144. Greco, K. V., Lara, P. F., Oliveira-Filho, R. M., Greco, R. V., and Sudo-Hayashi, L. S. (2006) Lymphatic regeneration across an incisional wound: inhibition by dexamethasone and aspirin, and acceleration by a micronized purified flavonoid fraction. Eur. J. Pharmacol. 551, 131-142
145. Boardman, K. C., and Swartz, M. A. (2001) Lymphangiogenesis in a mouse tail model. Bioeng. Conf. 50, 671-672
146. Loughman, M. S., Chatzistefanou, K., Gonzalez, E. M., Flynn, E., Adamis, A. P., Shing, Y., D'Amato, R. J., and Folkman, J. (1996) Experimental corneal neovascularisation using sucralfate and basic fibroblast growth factor. Aust. N. Z. J. Ophthalmol. 24, 289-295
147. Cursiefen, C., Maruyama, K., Jackson, D. G., Streilein, J. W., and Kruse, F. E. (2006) Time course of angiogenesis and lymphangiogenesis after brief corneal inflammation. Cornea 25, 443-447
148. Streilein, J. W., Bradley, D., Sano, Y., and Sonoda, Y. (1996) Immunosuppressive properties of tissues obtained from eyes with experimentally manipulated corneas. Invest. Ophthalmol. Vis. Sci. 37, 413-424
149. Cursiefen, C., Chen, L., Borges, L. P., Jackson, D., Cao, J., Radziejewski, C., D'Amore, P. A., Dana, M. R., Wiegand, S. J., and Streilein, J. W. (2004) VEGF-A stimulates lymphangiogenesis and hemangiogenesis in inflammatory neovascularization via macrophage recruitment. J. Clin. Invest. 113, 1040 -1050
150. Jiang, D., Hu, Y., and Ling, S. (2004) Expression of VEGF-C in rat cornea after alkali injury. J. Huazhong Univ. Sci. Technolog. Med. Sci. 24, 483-485
151. Bock, F., Onderka, J., Dietrich, T., Bachmann, B., Pytowski, B., and Cursiefen, C. (2008) Blockade of VEGFR3-signalling specifically inhibits lymphangiogenesis in inflammatory corneal neovascularisation. Graefes Arch. Clin. Exp. Ophthalmol. 246, 115-119
152. Hos, D., Bachmann, B., Bock, F., Onderka, J., and Cursiefen, C. (2008) Age-related changes in murine limbal lymphatic vessels and corneal lymphangiogenesis. Exp. Eye. Res. 87, 427-432
153. Maruyama, K., Ii, M., Cursiefen, C., Jackson, D. G., Keino, H., Tomita, M., Van Rooijen, N., Takenaka, H., D'Amore, P. A., Stein-Streilein, J., Losordo, D. W., and Streilein, J. W. (2005) Inflammation-induced lymphangiogenesis in the cornea arises from CD11b-positive macrophages. J. Clin. Invest. 115, 2363-2372
154. Hoffmann, F., Zhang, E. P., Mueller, A., Schulte, F., Foss, H. D., Franke, J., and Coupland, S. E. (2001) Contribution of lymphatic drainage system in corneal allograft rejection in mice. Graefes Arch. Clin. Exp. Ophthalmol. 239, 850-858
155. Chang, L. K., Garcia-Cardena, G., Farnebo, F., Fannon, M., Chen, E. J., Butterfield, C., Moses, M. A., Mulligan, R. C., Folkman, J., and Kaipainen, A. (2004) Dose-dependent response of FGF-2 for lymphangiogenesis. Proc. Natl. Acad. Sci. U. S. A. 101, 11658-11663
156. Cao, R., Bjorndahl, M. A., Religa, P., Clasper, S., Garvin, S., Galter, D., Meister, B., Ikomi, F., Tritsaris, K., Dissing, S., Ohhashi, T., Jackson, D. G., and Cao, Y. (2004) PDGF-BB induces intratumoral lymphangiogenesis and promotes lymphatic metastasis. Cancer Cell 6, 333-345
157. Morisada, T., Oike, Y., Yamada, Y., Urano, T., Akao, M., Kubota, Y., Maekawa, H., Kimura, Y., Ohmura, M., Miyamoto, T., Nozawa, S., Koh, G. Y., Alitalo, K., and Suda, T. (2005) Angiopoietin-1 promotes LYVE-1-positive lymphatic vessel formation. Blood 105, 4649-4656
158. Cao, R., Bjorndahl, M. A., Gallego, M. I., Chen, S., Religa, P., Hansen, A. J., and Cao, Y. (2006) Hepatocyte growth factor is a lymphangiogenic factor with an indirect mechanism of action. Blood 107, 3531-3536
159. Okazaki, T., Ni, A., Baluk, P., Ayeni, O. A., Kearley, J., Coyle, A. J., Humbles, A., and McDonald, D. M. (2009) Capillary defects and exaggerated inflammatory response in the airways of EphA2-deficient mice. Am. J. Pathol. 174, 2388-2399
160. Halin, C., Tobler, N. E., Vigl, B., Brown, L. F., and Detmar, M. (2007) VEGF-A produced by chronically inflamed tissue induces lymphangiogenesis in draining lymph nodes. Blood 110, 3158-3167
161. Kajiya, K., Hirakawa, S., and Detmar, M. (2006) Vascular endothelial growth factor-A mediates ultraviolet B-induced impairment of lymphatic vessel function. Am. J. Pathol. 169, 1496-1503
162. Kajiya, K., Sawane, M., Huggenberger, R., and Detmar, M. (2009) Activation of the VEGFR-3 pathway by VEGF-C attenuates UVB-induced edema formation and skin inflammation by promoting lymphangiogenesis. J. Invest. Dermatol. 129, 1292-1298
163. Kajiya, K., Huggenberger, R., Drinnenberg, I., Ma, B., and Detmar, M. (2008) Nitric oxide mediates lymphatic vessel activation via soluble guanylate cyclase-alpha1beta1-impact on inflammation. FASEB J. 22, 530-537
164. Suematsu, S., and Watanabe, T. (2004) Generation of a synthetic lymphoid tissue-like organoid in mice. Nat. Biotechnol. 22, 1539-1545
165. Okamoto, N., Chihara, R., Shimizu, C., Nishimoto, S., and Watanabe, T. (2007) Artificial lymph nodes induce potent secondary immune responses in naive and immunodeficient mice. J. Clin. Invest. 117, 997-1007
166. Hirakawa, S., Kodama, S., Kunstfeld, R., Kajiya, K., Brown, L. F., and Detmar, M. (2005) VEGF-A induces tumor and sentinel lymph node lymphangiogenesis and promotes lymphatic metastasis. J. Exp. Med. 201, 1089-1099
167. Hirakawa, S., Brown, L. F., Kodama, S., Paavonen, K., Alitalo, K., and Detmar, M. (2007) VEGF-C-induced lymphangiogenesis in sentinel lymph nodes promotes tumor metastasis to distant sites. Blood 109, 1010-1017
168. Halin, C., and Detmar, M. (2008) Inflammation, angiogenesis, and lymphangiogenesis. Methods Enzymol. 445, 1-25
169. Achen, M. G., and Stacker, S. A. (2008) Molecular control of lymphatic metastasis. Ann. N. Y. Acad. Sci. 1131, 225-234
170. Mumprecht, V., and Detmar, M. (2009) Lymphangiogenesis and cancer metastasis. [E-pub ahead of print] J. Cell. Mol. Med. PMID: 19583813
171. Karpanen, T., Egeblad, M., Karkkainen, M. J., Kubo, H., Yla-Herttuala, S., Jaattela, M., and Alitalo, K. (2001) Vascular endothelial growth factor C promotes tumor lymphangiogenesis and intralymphatic tumor growth. Cancer Res. 61, 1786-1790
172. Mattila, M. M., Ruohola, J. K., Karpanen, T., Jackson, D. G., Alitalo, K., and Harkonen, P. L. (2002) VEGF-C induced lymphangiogenesis is associated with lymph node metastasis in orthotopic MCF-7 tumors. Int. J. Cancer 98, 946-951
173. Skobe, M., Hawighorst, T., Jackson, D. G., Prevo, R., Janes, L., Velasco, P., Riccardi, L., Alitalo, K., Claffey, K., and Detmar, M. (2001) Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis. Nat. Med. 7, 192-198
174. Matsui, J., Funahashi, Y., Uenaka, T., Watanabe, T., Tsuruoka, A., and Asada, M. (2008) Multi-kinase inhibitor E7080 suppresses lymph node and lung metastases of human mammary breast tumor MDA-MB-231 via inhibition of vascular endothelial growth factor-receptor (VEGF-R) 2 and VEGF-R3 kinase. Clin. Cancer Res. 14, 5459-5465
175. Stacker, S. A., Caesar, C., Baldwin, M. E., Thornton, G. E., Williams, R. A., Prevo, R., Jackson, D. G., Nishikawa, S., Kubo, H., and Achen, M. G. (2001) VEGF-D promotes the metastatic spread of tumor cells via the lymphatics. Nat. Med. 7, 186-191
176. Padera, T. P., Kadambi, A., di Tomaso, E., Carreira, C. M., Brown, E. B., Boucher, Y., Choi, N. C., Mathisen, D., Wain, J., Mark, E. J., Munn, L. L., and Jain, R. K. (2002) Lymphatic metastasis in the absence of functional intratumor lymphatics. Science 296, 1883-1886
177. Kawakami, M., Yanai, Y., Hata, F., and Hirata, K. (2005) Vascular endothelial growth factor C promotes lymph node metastasis in a rectal cancer orthotopic model. Surg. Today 35, 131-138
178. Yanai, Y., Furuhata, T., Kimura, Y., Yamaguchi, K., Yasoshima, T., Mitaka, T., Mochizuki, Y., and Hirata, K. (2001) Vascular endothelial growth factor C promotes human gastric carcinoma lymph node metastasis in mice. J. Exp. Clin. Cancer Res. 20, 419-428
179. He, Y., Kozaki, K., Karpanen, T., Koshikawa, K., Yla-Herttuala, S., Takahashi, T., and Alitalo, K. (2002) Suppression of tumor lymphangiogenesis and lymph node metastasis by blocking vascular endothelial growth factor receptor 3 signaling. J. Natl. Cancer. Inst. 94, 819-825
180. Shibata, M. A., Morimoto, J., Shibata, E., and Otsuki, Y. (2008) Combination therapy with short interfering RNA vectors against VEGF-C and VEGF-A suppresses lymph node and lung metastasis in a mouse immunocompetent mammary cancer model. Cancer Gene Ther. 15, 776-786
181. Saito, N., Hamada, J. I., Furukawa, H., Tsutsumida, A., Oyama, A., Funayama, E., Saito, A., Tsuji, T., Tada, M., Moriuchi, T., and Yamamoto, Y. (2009) Laminin-421 produced by lymphatic endothelial cells induces chemotaxis for human melanoma cells. [E-pub ahead of print] Pigment Cell Melanoma Res. PMID: 19508413
182. Holopainen, T., Huang, H., Chen, C., Kim, K. E., Zhang, L., Zhou, F., Han, W., Li, C., Yu, J., Wu, J., Koh, G. Y., Alitalo, K., and He, Y. (2009) Angiopoietin-1 overexpression modulates vascular endothelium to facilitate tumor cell dissemination and metastasis establishment. Cancer Res. 69, 4656-4664
183. Papoutsi, M., Siemeister, G., Weindel, K., Tomarev, S. I., Kurz, H., Schachtele, C., Martiny-Baron, G., Christ, B., Marme, D., and Wilting, J. (2000) Active interaction of human A375 melanoma cells with the lymphatics in vivo. Histochem. Cell. Biol. 114, 373-385
184. Papoutsi, M., Sleeman, J. P., and Wilting, J. (2001) Interaction of rat tumor cells with blood vessels and lymphatics of the avian chorioallantoic membrane. Microsc. Res. Tech. 55, 100-107
185. Rinderknecht, M., and Detmar, M. (2008) Tumor lymphangiogenesis and melanoma metastasis. J. Cell. Physiol. 216, 347-354
186. Kaplan, R. N., Rafii, S., and Lyden, D. (2006) Preparing the "soil": the premetastatic niche. Cancer Res. 66, 11089-11093
187. Koyama, H., Kobayashi, N., Harada, M., Takeoka, M., Kawai, Y., Sano, K., Fujimori, M., Amano, J., Ohhashi, T., Kannagi, R., Kimata, K., Taniguchi, S., and Itano, N. (2008) Significance of tumor-associated stroma in promotion of intratumoral lymphangiogenesis: pivotal role of a hyaluronan-rich tumor microenvironment. Am. J. Pathol. 172, 179-193
188. Isaka, N., Padera, T. P., Hagendoorn, J., Fukumura, D., and Jain, R. K. (2004) Peritumor lymphatics induced by vascular endothelial growth factor-C exhibit abnormal function. Cancer Res. 64, 4400-4404
189. Mandriota, S. J., Jussila, L., Jeltsch, M., Compagni, A., Baetens, D., Prevo, R., Banerji, S., Huarte, J., Montesano, R., Jackson, D. G., Orci, L., Alitalo, K., Christofori, G., and Pepper, M. S. (2001) Vascular endothelial growth factor-C-mediated lymphangiogenesis promotes tumour metastasis. EMBO J. 20, 672-682
190. Kopfstein, L., Veikkola, T., Djonov, V. G., Baeriswyl, V., Schomber, T., Strittmatter, K., Stacker, S. A., Achen, M. G., Alitalo, K., and Christofori, G. (2007) Distinct roles of vascular endothelial growth factor-D in lymphangiogenesis and metastasis. Am. J. Pathol. 170, 1348-1361
191. Crnic, I., Strittmatter, K., Cavallaro, U., Kopfstein, L., Jussila, L., Alitalo, K., and Christofori, G. (2004) Loss of neural cell adhesion molecule induces tumor metastasis by up-regulating lymphangiogenesis. Cancer Res. 64, 8630-8638
192. Kren, A., Baeriswyl, V., Lehembre, F., Wunderlin, C., Strittmatter, K., Antoniadis, H., Fassler, R., Cavallaro, U., and Christofori, G. (2007) Increased tumor cell dissemination and cellular senescence in the absence of beta1-integrin function. EMBO J. 26, 2832-2842
193. Weninger, W., Partanen, T. A., Breiteneder-Geleff, S., Mayer, C., Kowalski, H., Mildner, M., Pammer, J., Sturzl, M., Kerjaschki, D., Alitalo, K., and Tschachler, E. (1999) Expression of vascular endothelial growth factor receptor-3 and podoplanin suggests a lymphatic endothelial cell origin of Kaposi's sarcoma tumor cells. Lab. Invest. 79, 243-251
194. Wang, H. W., Trotter, M. W., Lagos, D., Bourboulia, D., Henderson, S., Makinen, T., Elliman, S., Flanagan, A. M., Alitalo, K., and Boshoff, C. (2004) Kaposi sarcoma herpesvirusinduced cellular reprogramming contributes to the lymphatic endothelial gene expression in Kaposi sarcoma. Nat. Genet. 36, 687-693
195. Hong, Y. K., Foreman, K., Shin, J. W., Hirakawa, S., Curry, C. L., Sage, D. R., Libermann, T., Dezube, B. J., Fingeroth, J. D., and Detmar, M. (2004) Lymphatic reprogramming of blood vascular endothelium by Kaposi sarcoma-associated herpesvirus. Nat. Genet. 36, 683-685
196. Brambilla, L., Tourlaki, A., Ferrucci, S., Brambati, M., and Boneschi, V. (2006) Treatment of classic Kaposi's sarcomaassociated lymphedema with elastic stockings. J. Dermatol. 33, 451-456